{
  "schema_version": "1.3.1",
  "doc": {
    "doc_id": "2cc074782e7b7d66e6486325cfc43ed2",
    "title": "Ramsay Health Care Limited",
    "source_uri": "25.9月 普通个人版/9.1 普通个人版/BofA/Ramsay Health Care Limited Outlook disappointsRamsay Health Care Limited Outlook disappoints_2025-08-28",
    "language": "en",
    "timestamps": {
      "ingested_at": "2025-10-26T11:34:17.202778",
      "extracted_at": "2025-10-26T11:34:17.202790"
    },
    "extraction_run": {
      "vision_model": "deepseek-ai/DeepSeek-OCR",
      "synthesis_model": "rule-based-engine",
      "pipeline_steps": [
        "ocr",
        "rule_extraction",
        "figure_vision"
      ],
      "processing_metadata": {
        "pages_processed": 11,
        "successful_pages": 11,
        "date": "2025-08-28",
        "publication": "25.9月 普通个人版/9.1 普通个人版/BofA",
        "authors": [],
        "markdown_cleaning": {
          "removed_sections": 3,
          "removed_paragraphs": 2,
          "reduction_ratio": 0.19829609223548617
        },
        "input_relative_path": "25.9月 普通个人版/9.1 普通个人版/BofA"
      }
    }
  },
  "passages": [
    {
      "passage_id": "b9e55347b9f46af9",
      "text": "Reiterate Rating: NEUTRAL | PO: 39.00 AUD | Price: 34.09 A:1%",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "3699683c4c90d8db",
      "text": "Rev &#36;178b (+6%) in line with Cons., NPAT &#36;305m (+2%) beat Cons. (+2%). Key points:(1) AUS: Rev +4.3% on improved indexation and private volume growth, but -40bps EBIT margin decline; (2) UK Hosp: Rev +11.9%, volume growth/ mix and operational efficiencies drove +70bps EBIT margin; (3) Elysium: weakness continues, -360bps EBIT margin decline; (4) Europe: France remains challenged, partially offset by Nordics.",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "f99813e669c0edf7",
      "text": "No guidance provided. Today's commentary points to a challenging FY26 across all regions. Private hospitals play an important role in our health system and RHC stock is trading cheaply at 21x 12m forward P/E. However, near-term volume and margin challenges persist. Uncertainty on Sante remains. We cut our estimates following today's result (see Exhibit 2). This lowers our 50:50 DCF:P/E derived PO to &#36;39 from &#36;42. Reiterate Neutral on balanced risk-reward.",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "0ba5a5d268e74d33",
      "text": "The usual positive vibes from AUS were absent today with 2H25 EBIT down 4.2% as public hospitals, QLD weather, and digital and data spend dragged on earnings. Despite continued public sector challenges. RHC expects FY26 EBIT growth supported by private hospital activity recovery. We forecast modest EBIT growth (+2%) given Peel contract loss and lower Jondalup pricing. RHC aims to keep digital, and data spend flat in FY26.",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "97bcb1bb94c79edb",
      "text": "Green shoots from UK hospitals with higher NHS volumes and tariff indexation. Elysium occupancy challenges to persist into FY26 and margin improvement initiatives unlikely impact financials for 12-18 months. BofAe Elysium: &#36;17m FY26 EBIT loss (FY25 -&#36;42m).",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "1da283d6ab7367f4",
      "text": "We await Sante outcome. RHC acknowledged all possibilities were under consideration but provided no colour on options nor decision time frame. Margin expansion remains difficult given French Government funding cuts and modest 0.5% Mar25 tariff increase.",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "9affe1d35c538c17",
      "text": "Estimates (Jun) (A$)2024A2025A2026E2027E2028ENet Income (Reported - mn)89024308460592EPS1.110.0301.281.942.52Consensus EPS (Visible Alpha)1.611.982.34EPS Change (YoY)-10.8%-97.3%NM51.4%29.4%Dividend/ Share0.6500.8000.9381.051.45Free Cash Flow / Share(8.93)3.063.444.004.06Valuation (Jun)P/E Core30.60x1,153.04x26.55x17.53x13.55xDividend Yield1.91%2.35%2.75%3.09%4.27%EV/ EBITDA*6.27x6.40x5.96x5.35x4.93xFree Cash Flow/Tetd*-25.98%8.95%10.05%11.68%11.87%",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "69ec7b6c9b222906",
      "text": "* For full definitions of Qmethod™ measures, see page 8.",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "5591bfa9eab0a0cf",
      "text": "&gt;&gt; Employed by a non-US affiliate of BofAS and is not registered/qualified as a research analyst under the FINRA rules.",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "c8cad0b743cb87f9",
      "text": "Refer to 'Other Important Disclosures' for information on certain BofA Securities entities that take responsibility for the information herein in particular jurisdictions.",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "dd1c44fdb71baaf6",
      "text": "**BofA Securities** **does** **and** **seeks** **to** **do** **business** **with** **issuers** **covered** **in** **its** **research** **reports.** **As** **a** **result,** **investors** **should** **be** **aware** **that** **the** **firm** **may** **have** **a** **conflict** **of** **interest** **that** **could** **affect** **the** **objectivity** **of** **this** **report.** **Investors** **should** **consider** **this** **report** **as** **only** **a** **single** **factor** **in** **making** **their** **investment** **decision.**",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "5f166ca4faba45dd",
      "text": "Refer to important disclosures on page 9 to 11. Analyst Certification on page 6. Price **Objective** **Basis/Risk** **on** **page** **6.**",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "7d57df24adc2c549",
      "text": "Key Changes(AS)PreviousCurrentPrice Obj.42.0039.002026E EPS1.651.282027E EPS2.211.942028E EPSNA2.52",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "df9e2978124f7324",
      "text": "**Lyanne Harrison** &gt;&gt;",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "cb3efe0f6dc9a3c6",
      "text": "Merrill Lynch (Australia)",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "2e62e138c503a283",
      "text": "**Elizabeth Davies** &gt;&gt;",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "6a3b5dc0ecf78f2e",
      "text": "Merrill Lynch (Australia)",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "8b3d636cdfb24426",
      "text": "Stock DataPrice34.09 AUDPrice Objective39.00 AUDDate Established28-Aug-2025Investment OpinionA-2-752-Week Range31.66 AUD-45.96 AUDMkt Val / Shares Out (mn)5,104 USD / 230.8Market Value (mn)7,869 AUDAverage Daily Value (mn)13.10 USDFree Float78.4%BofA Ticker / ExchangeRMSYF / ASXBloomberg / ReutersRHC AU / RHC AXROE (2026E)6.4%Net Dbt to Eqty (Jun-2025A)83.3%",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "79de1d4a5051414d",
      "text": "NHS: National Health Service",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "cf4e22ad35fa2495",
      "text": "PHI: Private Health Insurers",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "b338dd58d9927f43",
      "text": "RHC: Ramsay Healthcare",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "e7d7d9a22fb95af3",
      "text": "WA: Western Australia",
      "page": 0,
      "section": null
    },
    {
      "passage_id": "777ab93acb130693",
      "text": "Key Income Statement Data (Jun)2024A2025A2026E2027E2028E(AS Millions)Sales16,77917,83718,77819,58320,088Associates &amp;amp; Other Revenue00000Operating Expenses(14,646)(15,677)(16,453)(17,007)(17,288)EBITDA2,1332,1592,3252,5772,799Depreciation &amp;amp; Amortization(1,128)(1,126)(1,230)(1,280)(1,312)EBIT1,0051,0331,0961,2961,487Net Interest &amp;amp; Other income(620)(604)(591)(561)(541)Pretax Income385429505735946Tax (expense) / Benefit(121)(56)(167)(235)(303)Outside Equity interest in NpatNANANANANAPreference dividendsNANANANANANet Profit b/f Abnormal263373338500643Non-Recurring Items626(349)(30)(40)(51)Net Income (Reported)89024308460592Key Cash Flow Statement DataEBITDA2,1332,1592,3252,5772,799Change in Working Capital002315722Other Cflow Items before int &amp;amp; tax00000Net Interest Paid00000Tax Paid(124)(210)(167)(235)(303)Other Cflow from Operations(3,299)(468)(591)(561)(541)Cash Flow from Operations(1,290)1,4811,5911,9371,977Capital Expenditure (PP&amp;amp;E)(754)(777)(800)(1,018)(1,043)(Acquisition) / Disposal of Investments00000Other Cflow from Investing91411000Cash Flow from Investing160(765)(800)(1,018)(1,043)Shares Issue / (Repurchase)00000Dividend paid(158)(191)(216)(242)(334)Other Cflow from Financing(1,292)(440)(860)(678)(600)Cash Flow from Financing(1,450)(631)(1,075)(919)(934)Free Cash Flow(2,044)704791919934Net Debt4,4224,7534,7854,7144,722",
      "page": 1,
      "section": null
    },
    {
      "passage_id": "38fb24cccc5afacc",
      "text": "Key Balance Sheet DataCash Equivalents662784500500500Receivables &amp;amp; Inventories3,0093,0183,3333,1893,268Property, Plant &amp;amp; Equipment5,3845,8206,0446,4646,893Intangibles6,1406,4316,3086,1796,047Other assets5,7006,4226,1905,9385,672Total Assets20,89422,47622,37622,26922,379Payables3,3613,5773,9153,9274,028Provisions517551551551551Short term debt &amp;amp; Long term debt5,0845,5375,2855,2145,222Other Liabilities6,4057,1026,7956,4876,180Total Liabilities15,36716,76716,54516,18015,981Total Equity5,5285,7095,8316,0906,398",
      "page": 1,
      "section": null
    },
    {
      "passage_id": "8836057af1f6f7f8",
      "text": "Short term debt &amp;amp; Long term debt5,0845,5375,2855,2145,222Other Liabilities6,4057,1026,7956,4876,180Total Liabilities15,36716,76716,54516,18015,981Total Equity5,5285,7095,8316,0906,398iQmethod™ - Bus Performance*Return on Capital Employed4.0%5.2%4.2%5.1%5.8%Return on Equity5.9%0.1%6.4%9.3%11.4%Operating Margin6.0%5.8%5.8%6.6%7.4%EBITDA Margin12.7%12.1%12.4%13.2%13.9%iQmethod™ - Quality of Earnings*Cash Realization Ratio-5.1x217.8x5.4x4.3x3.4xDividend Payout Ratio58.3%2,705.9%73.0%54.1%57.8%Tax Rate (Reported)31.5%12.9%33.0%32.0%32.0%Net Debt-to-Equity Ratio80.0%83.3%82.0%77.4%73.8%Interest Cover1.6x1.7x1.8x2.3x2.7x",
      "page": 1,
      "section": null
    },
    {
      "passage_id": "df19c793071acce3",
      "text": "Key MetricsFranking100%100%100%100%100%",
      "page": 1,
      "section": null
    },
    {
      "passage_id": "bba6f3db1091efd7",
      "text": "\\\\* For full definitions of iQmethod measures, see page 8.",
      "page": 1,
      "section": null
    },
    {
      "passage_id": "f832dce67129ac62",
      "text": "\\(+7.9\\%\\) private hospital revenue increase driven by \\(2.7\\%\\) volume growth and higher indexation. Throughout FY25 RHC negotiated improved revenue indexation with all major PHIs. Admissions saw strong growth across the three core areas: \\((1) + 3.2\\%\\) in Surgical treatments; \\((2) + 2.7\\%\\) in private funding; \\((3) + 3.1\\%\\) in day admissions (day patients now represent \\(68.7\\%\\) of total admissions). RHC reported a \\(+300\\) bps pcp increase in utilisation, showing strengthening utilisation despite expanded procedural capacity.",
      "page": 2,
      "section": null
    },
    {
      "passage_id": "eb4d0a30b8e48e28",
      "text": "AUS U/EBIT grew \\(+1.1\\%\\) . Drag from higher operational costs at Joondalup public hospital and the handover of the Peel Hospital Campus. The new Joondalup public agreement is impacting performance, as the funding mechanism is linked to the WA 'State Price', which has not kept up with cumulative cost inflation. RHC expects a \\(- 537m\\) impact to EBIT. RHC also flagged longer lengths of stay from more complex cases coming through the public private emergency departments resulting in bed blocks.",
      "page": 2,
      "section": null
    },
    {
      "passage_id": "5c62530b9d5aea69",
      "text": "RHC saw a \\(\\) 24m\\(increase to the digital and data Opex in FY25, to\\) \\ \\(89m\\) ( \\(\\) 19m\\(less than planned), driven by their digital transformation program announced at the FY25 investor day. RHC expects FY26 digital and data spend to be in line with FY25. The program is aimed at improving: (1) productivity through analytics (theatre staffing and utilisation); (2) clinical documentation using AI (3); digitising the patient experience and enabling integrated care; (4) procurement optimisation.",
      "page": 2,
      "section": null
    },
    {
      "passage_id": "47c7a39c50a0ed40",
      "text": "RHC guiding FY26 capex spend to be \\(\\) 410- 440m\\(, including\\) \\ \\(200 - 250m\\) for development projects, primarily to expand procedural capacity in major hospital catchments. 21 new theatres are due to open in FY26.",
      "page": 2,
      "section": null
    },
    {
      "passage_id": "be16c60668a4eb42",
      "text": "Elysium turnaround protractedElysium saw a \\(- 360\\) bps EBIT margin decline due to lower occupancy, cost inflation and restructure. \\(+14\\%\\) rev growth primarily driven by \\(+8.2\\%\\) increase in average daily fee and \\(+10.3\\%\\) in specialising revenue. RHC noted continued weakness into 2H25 particularly in Neuro and Rehab and flagged a drop in demand from NHS for acute services. Elysium saw a net increase to beds (despite closing 94 throughout the year), with lower occupancy and opening of new sites contributing to the \\(- 360\\) bps EBIT margin decline.",
      "page": 2,
      "section": null
    },
    {
      "passage_id": "6ac8da0225cc5962",
      "text": "Significant uncertainties remain an overhang for Sante regarding private hospital funding and political outlook. FY25 earnings were impacted by a €53 decline in funding. Despite a reduction in general cost inflation, significant potential wage inflation from union pressure in France remains. RHC displayed capital discipline in FY25 reducing Europe capex spend by €24m.",
      "page": 2,
      "section": null
    },
    {
      "passage_id": "cce6aab7b5e0fe42",
      "text": "RHC commented they are working through the options of the Sante exit, however did not provide any additional detail into potential options or guide to a timeframe.",
      "page": 2,
      "section": null
    },
    {
      "passage_id": "c576ce328e2df8be",
      "text": "Exhibit 1: Rev \\(\\) 17.8b\\$ inline with Cons, NPAT \\(\\) 305m\\$ beat Cons \\((+2\\%)\\) FY25 vs BofAe vs Consensus",
      "page": 3,
      "section": null
    },
    {
      "passage_id": "4baecacb0a22c7a7",
      "text": "ASFY24AFY25EChange (%)vs BofAevs ConsensusFY25EDiff (%)FY25EDiff (%)Revenue$m16,77017,8396%17,5861%17,8310%EBITDA$m2,1122,1693%2,185-1%2,192-1%EBIT$m1,0341,0431%1,083-4%1,0301%NPAT (to owners parent)$m3003052%3011%3002%Pre share metricsFY24AFY25EFY25EDiff (%)FY25EDiff (%)EPS (post CARES dividend, diluted)$/shr1.111.2512%1.250%1.232%DPS$/shr0.650.8023%0.749%0.8-1%AnalysisFY24AFY25EpptsFY25EpptsFY25EpptsEBITDA margin%12.6%12.2%-0.412.4%-0.312.3%-0.1EBIT margin%6.2%5.8%-0.36.2%-0.35.8%0.1NPAT margin%1.8%1.7%-0.11.7%0.01.7%0.0",
      "page": 3,
      "section": null
    },
    {
      "passage_id": "8ad76dcd8097eed9",
      "text": "Source: BofA Global Research estimates",
      "page": 3,
      "section": null
    },
    {
      "passage_id": "571a1b5754c58101",
      "text": "Exhibit 2: BofAe FY26 NPAT of &#36;308m on operational challenges across AUS, Elysium and Europe",
      "page": 4,
      "section": null
    },
    {
      "passage_id": "836133eee29acad7",
      "text": "Changes to our estimates",
      "page": 4,
      "section": null
    },
    {
      "passage_id": "cffb959bf62cf32c",
      "text": "FY26EFY27EFY28ENewOldChg %NewOldChg %NewOldCh&gt;%RevenueSm18,77818,3292.5%19,58319,0942.6%20,08819,5872.6%EBITDASm2,3252,358-1.4%2,5772,5720.2%2,7992,7322.5%EBITSm1,0961,213-9.7%1,2961,342-3.4%1,4871,4711.1%Underlying NPATSm338420-19.5%500558-10.4%643657-2.2%NPAT to owners of parentSm308390-21.0%460518-11.3%592610-3.1%Per share metricsEPS (post CARES, diluted)&#36;/shr1.281.65-22.1%1.942.21-12.0%2.522.61-3.6%DPS&#36;/shr0.940.94-0.5%1.051.24-15.3%1.451.56-6.8%AnalysisEBITDA margin%12.4%12.9%-0.513.2%13.5%-0.313.9%13.9%0.0EBIT margin%5.8%6.6%-0.86.6%7.0%-0.47.4%7.5%-0.1Net margin%1.6%2.1%-0.52.3%2.7%-0.42.9%3.1%-0.2",
      "page": 4,
      "section": null
    },
    {
      "passage_id": "f3d057ee7fd71aa1",
      "text": "Source: BofA Global Research estimates",
      "page": 4,
      "section": null
    },
    {
      "passage_id": "f3e2279f03ebb0fd",
      "text": "BofA GLOBAL RESEARCH",
      "page": 4,
      "section": null
    },
    {
      "passage_id": "f2fa2ecb194e675a",
      "text": "We make the following changes for FY26:",
      "page": 4,
      "section": null
    },
    {
      "passage_id": "5af456a0b88dfedd",
      "text": "· AUS: (1) lower FY26 EBITDA margin from 14% to 13.2% reflecting lower margin Joondalup contract following state price funding. We forecast AUS EBIT to grow by 2% in FY26",
      "page": 4,
      "section": null
    },
    {
      "passage_id": "0da6017f59b6d9c4",
      "text": "· UK: (1) increase hospital revenue growth to 10% (from 7%) reflecting higher NHS volumes",
      "page": 4,
      "section": null
    },
    {
      "passage_id": "5723afed66a024ee",
      "text": "· Elysium: (1) Lower EBITDA margin to 6% (from 11%) reflect more challenging trading conditions. We forecast Elysium to generate an EBIT loss of &#36;17m in FY26 (compared to &#36;42m loss in FY25)",
      "page": 4,
      "section": null
    },
    {
      "passage_id": "090ad1cf8313121d",
      "text": "· France: (1) Increase revenue growth to 5% (from 3%) but lower EBITDA margin from 13.2% to 12.3% in line with FY25 margins",
      "page": 4,
      "section": null
    },
    {
      "passage_id": "752af2f513108a95",
      "text": "· Nordics: no changes",
      "page": 4,
      "section": null
    },
    {
      "passage_id": "90512e54900b5afb",
      "text": "· Increase interest expense to &#36;606m given RHC guidance of &#36;600-&#36;620m",
      "page": 4,
      "section": null
    },
    {
      "passage_id": "3beba48c647a6556",
      "text": "· Lower capex to &#36;800m (from &#36;975m) in line with RHC guidance of &#36;755-&#36;835m",
      "page": 4,
      "section": null
    },
    {
      "passage_id": "cda5494f57597f30",
      "text": "Our price objective for RHC of A\\\\$39/share is based on a blended discounted cash flow and multiple based valuation methodology.",
      "page": 5,
      "section": null
    },
    {
      "passage_id": "c8ce996f2080e811",
      "text": "DCF valuation uses a WACC of \\(7.3\\%\\) with a \\(1.5\\%\\) risk free rate and \\(7\\%\\) equity risk premium, and a \\(3\\%\\) terminal growth rate. The multiple based valuation uses a FY25/26e EPS and a P/E multiple of 25x.",
      "page": 5,
      "section": null
    },
    {
      "passage_id": "856072306a6b605f",
      "text": "Risks to our price objective are declines in private health insurance membership, unfavourable renegotiations with private health insurers, inflation and cost of living risk, and delays in brownfield sites. Positive risks are faster volume recovery than expected, potential acquisitive growth in new markets, or regulatory reform opportunities in existing markets having a materially positive impact on earnings.",
      "page": 5,
      "section": null
    },
    {
      "passage_id": "c1fa3394fa16d72f",
      "text": "APR-Healthcare Coverage Cluster",
      "page": 6,
      "section": null
    },
    {
      "passage_id": "7119240e07ed0bf9",
      "text": "Investment ratingCompanyBofA TickerBloomberg symbolAnalystJinxin FertilityJXFG1951 HKEthan CuiJinyu Bio-TechXMTDF600201 CHDavid LiJMOCJMDCF4483 JPRitsuo WatanabeKyowa KirinKYKOF4151 JPKoichi MameganoMedleyXEQNF4480 JPRitsuo WatanabeMindrayXDWF300760 CHSandra SunNxera PharmaSOLTF4565 JPKoichi MameganoOtsuka HDOTSKF4578 JPKoichi MameganoOtsuka HDOTSKYOTSKY USKoichi MameganoPharmaronPHBBF3759 HKDavid LiPolynovoCALZFPNV AULyanne HarrisonParam 9 HospitalXPNHFPR9 TBTeerapol Udomvej, CFAResMed IncRSMDFRMD AULyanne HarrisonResMed Inc.RMDRMD USLyanne HarrisonSanten Pharm.SNPHF4536 JPKoichi MameganoSawai Group HoldingsSWGHF4887 JPRitsuo WatanabeShanghai PharmaceuticalsSHPMF2607 HKDavid LiShanghai United ImagingXCAOF688271 CHSandra SunSHIMADZUSHMZF7701 JPRitsuo WatanabeShionogiSGIQF4507 JPKoichi MameganoShionogiSGIQYSGIQY USKoichi MameganoSino BiopharmSBMFF1177 HKDavid LiSinopharmSHTDF1099 HKDavid LiSonic Healthcare LimitedSKHCFSHL AULyanne HarrisonSysmexSSMXF6869 JPRitsuo WatanabeTakeda Pharm.TKPHF4502 JPKoichi MameganoTakeda Pharm.TAKTAK USKoichi MameganoTerumoTRUMF4543 JPRitsuo WatanabeTigerMedHTMDF3347 HKDavid LiWuxi ApptecWUXIF2359 HKDavid LiWuxi ApptecXLUHF603259 CHDavid LiYunnan BaiyaoYBAIF000538 CHSandra SunZhifeiXCHOF300122 CHDavid Li",
      "page": 6,
      "section": null
    },
    {
      "passage_id": "0cc6e9fc498c8156",
      "text": "AlkemXAMLFALKEM INNeha ManpuriaAsahi IntecAHICF7747 JPRitsuo WatanabeAstellas PharmaALPMF4503 JPKoichi MameganoAstellas PharmaALPMYALPMY USKoichi MameganoBangkok Dusit Medical ServicesBDMSFBDMS TBTeerapol Udomvej, CFAChugai Pharm.CHGCF4519 JPKoichi MameganoCochlear LimitedCHEOFCOH AULyanne HarrisonEBOS Group LimitedEBOSFEBO NZLyanne HarrisonEBOS Group LimitedXEBOFEBO AULyanne HarrisonEverest MedicineXMKLF1952 HKDavid LiFisher &amp;amp; Paykel HealthcareXPXAFFPH AULyanne HarrisonFisher &amp;amp; Paykel HealthcareFSPKFFPH NZLyanne HarrisonFujifilm HoldingsFUJIF4901 JPRitsuo WatanabeFUJIFILM HoldingsFUJIFFUJIF USRitsuo WatanabeKelun-BiotechXSKBF6990 HKDavid LiLupinXEFSFLPC INNeha ManpuriaM3MTHRF2413 JPRitsuo WatanabeMax HealthcareXMHLFMAXHEALT INNeha ManpuriaNew Industries Biomedical EngineeringXSNQF300832 CHSandra SunOlympus Corp.OCPNF7733 JPRitsuo WatanabeRamsay Health Care LimitedRMSYFRHC AULyanne HarrisonTopchoice MedicalXZDXF600763 CHEthan CuiTorrent PharmaTOPHFTRP INNeha ManpuriaWuXi BiologicsWXIBF2269 HKDavid LiZai LabZLABZLAB USDavid LiZai LabXCDZF9688 HKDavid LiZydus LifesciencesXMQLFZYDUSLIF INNeha Manpuria",
      "page": 6,
      "section": null
    },
    {
      "passage_id": "79fbc2b43052983d",
      "text": "Ain HoldingsAINPF9627 JPRitsuo WatanabeAsymchem LaboratoriesXALPF002821 CHDavid Li",
      "page": 6,
      "section": null
    },
    {
      "passage_id": "30b4c40df7a11ea7",
      "text": "APR-Healthcare Coverage Cluster",
      "page": 7,
      "section": null
    },
    {
      "passage_id": "41737d46d840d33a",
      "text": "Investment ratingCompanyBofA TickerBloomberg symbolAnalystAutobio Diagnostics Co LtdXQDXF603658 CHSandra SunBaiyunshanXOUFF600332 CHSandra SunBeijing Wantai Biological PharmacyXBHIF603392 CHDavid LiCiplaXCLAFCIPLA INNeha ManpuriaCSPC PharmaceuticalCHJTF1093 HKEthan CuiEisaiESALF4523 JPKoichi MameganoFrontageFGHQF1521 HKDavid LiHelalus LimitedPHCRFHLS AULyanne HarrisonHengrui MedicineXMOKF600276 CHDavid LiJoin LabXQTSF6127 HKDavid LiJoin LabJOLCF603127 CHDavid LiMankind PharmaXDXZFMANKIND INNeha ManpuriaMedipal HoldingsMEPDF7459 JPRitsuo WatanabeOno Pharm.OPHLF4528 JPKoichi MameganoOvtekXOCKF300595 CHDavid LiPharmaronXLYGF300759 CHDavid LiPHC HoldingsPHCCF6523 JPRitsuo WatanabePien Tze HuangXUVHF600436 CHSandra SunShanghai PharmaceuticalsXKCRF601607 CHDavid LiSMSSMSZF2175 JPRitsuo WatanabeSun PharmaXPUCFSUNP INNeha ManpuriaTigerMedXHTHF300347 CHDavid LiYifeng PharmacyXYHCF603939 CHEthan CuiRSTRMicroPortMCRPF853 HKSandra SunTRYTXHXTF9164 JPRitsuo Watanabe",
      "page": 7,
      "section": null
    },
    {
      "passage_id": "4d70c4e9b3c7dba0",
      "text": "Business PerformanceNumeratorDenominatorReturn On Capital EmployedNOPAT = (EBIT + Interest Income) × (1 – Tax Rate) + Goodwill AmortizationTotal Assets – Current Liabilities + ST Debt + Accumulated Goodwill AmortizationReturn On EquityNet IncomeShareholders&#x27; EquityOperating MarginOperating ProfitSalesEarnings GrowthExpected 5 Year CAGR From Latest ActualN/AFree Cash FlowCash Flow From Operations – Total CapexN/AQuality of EarningsNumeratorDenominatorCash Realization RatioCash Flow From OperationsNet IncomeAsset Replacement RatioCapexDepreciationTax RateTax ChargePre-Tax IncomeNet Debt-To-Equity RatioNet Debt = Total Debt – Cash &amp;amp; EquivalentsTotal EquityInterest CoverEBITInterest ExpenseValuation ToolkitNumeratorDenominatorPrice / Earnings RatioCurrent Share PriceDiluted Earnings Per Share (Basis As Specified)Price / Book ValueCurrent Share PriceShareholders&#x27; Equity / Current Basic SharesDividend YieldAnnualised Declared Cash DividendCurrent Share PriceFree Cash Flow YieldCash Flow From Operations – Total CapexMarket Cap = Current Share Price × Current Basic SharesEnterprise Value / SalesEV = Current Share Price × Current Shares + Minority Equity + Net Debt + Other LT LiabilitiesSalesEV / EBITDAEnterprise ValueBasic EBIT + Depreciation + Amortization",
      "page": 7,
      "section": null
    },
    {
      "passage_id": "ee64a4931b1de9bf",
      "text": "Qmethod is the set of BofA Global Research standard measures that serve to maintain global consistency under three broad headings: Business Performance, Quality of Earnings, and validations. The key features of iQmethod are: A consistently structured, detailed, and transparent methodology. Guidelines to maximize the effectiveness of the comparative valuation process, and to identify some common pitfalls. iQatobase is our real-time global research database that is sourced directly from our equity analysts' earnings models and includes forecasted as well as historical data for income statements, balance sheets, and cash flow statements for companies covered by BofA Global Research.",
      "page": 7,
      "section": null
    },
    {
      "passage_id": "a5440e4495a0821b",
      "text": "Profile, iQmethod and service marks of Bank of America Corporation. iQatobase is a registered service mark of Bank of America Corporation.",
      "page": 7,
      "section": null
    },
    {
      "passage_id": "020ca9f362f17358",
      "text": "orptio, in  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t  t  t  t  t  i  t  t  t  t  t  t  t  t  t  t  e  t  t  t  t  t",
      "page": 9,
      "section": null
    },
    {
      "passage_id": "18621d7a9db7aa9a",
      "text": "s    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t    t    t    e    t    t    t    t    t    t    t    t    t    t    s    t    t    t    t    t    t    t",
      "page": 10,
      "section": null
    }
  ],
  "entities": [
    {
      "entity_id": "a0a6812a4b275534",
      "name": "AS Millions",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "101d9e0274c5aa25",
      "name": "Accumulated Goodwill",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "645f128997f142a3",
      "name": "Ain Holdings",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "0932cb8d2b0b0ac7",
      "name": "America Corporation",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "517917b86efb07cf",
      "name": "Analyst Certification",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "838ea06ba425dee0",
      "name": "Annualised Declared",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "cb358c677450e407",
      "name": "Asahi Intec",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "687cd03d96e468d6",
      "name": "Asset Replacement",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "88e7c22574311b3f",
      "name": "Astellas Pharma",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "d7ca112168434181",
      "name": "Asymchem Laboratories",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "b681ac93ea9ea0b6",
      "name": "Autobio Diagnostics",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "3206071e540e388b",
      "name": "Autobio Diagnostics Co Ltd",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "c509a51f8c52c423",
      "name": "Average Daily",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "6b3368b1825872cb",
      "name": "Bangkok Dusit",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "fdcfb87823fd5cca",
      "name": "Bank of America Corporation",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "65a05a319cb29494",
      "name": "Basic EBIT",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "24625ca1b4d9b449",
      "name": "Basis As",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "83225c63e686faf6",
      "name": "Beijing Wantai",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "c6b6c848afd6c7d8",
      "name": "Biological Pharmacy",
      "type": "company",
      "aliases": []
    },
    {
      "entity_id": "84cabe7d46a70133",
      "name": "Biomedical Engineering",
      "type": "company",
      "aliases": []
    }
  ],
  "data": {
    "figures": [
      {
        "type": "other",
        "title": null,
        "page": 1,
        "axes": null,
        "series": [],
        "figure_id": "f260e6f73444dbc8",
        "provenance": {
          "page": 1
        }
      }
    ],
    "tables": [],
    "numerical_data": [
      {
        "num_id": "88bf8849b366a375",
        "value": 0.01,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "lth Care Limited # Outlook disappoints Reiterate Rating: NEUTRAL | PO: 39.00 AUD | Price: 34.09 A:1% ![Figure 0-0](images/0_0.jpg) # FY25 result okay... Rev &#36;178b (+6%) in line with Cons., NPAT",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "5c2b3cd97599e6f2",
        "value": 0.06,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "39.00 AUD | Price: 34.09 A:1% ![Figure 0-0](images/0_0.jpg) # FY25 result okay... Rev &#36;178b (+6%) in line with Cons., NPAT &#36;305m (+2%) beat Cons. (+2%). Key points:(1) AUS: Rev +4.3% on improv",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "133eeeeb0ef3800d",
        "value": 0.02,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "-0](images/0_0.jpg) # FY25 result okay... Rev &#36;178b (+6%) in line with Cons., NPAT &#36;305m (+2%) beat Cons. (+2%). Key points:(1) AUS: Rev +4.3% on improved indexation and private volume growth,",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "1e6d857237d26538",
        "value": 0.02,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "g) # FY25 result okay... Rev &#36;178b (+6%) in line with Cons., NPAT &#36;305m (+2%) beat Cons. (+2%). Key points:(1) AUS: Rev +4.3% on improved indexation and private volume growth, but -40bps EBIT ",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "e8256fe210a6d9a9",
        "value": 0.043,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "&#36;178b (+6%) in line with Cons., NPAT &#36;305m (+2%) beat Cons. (+2%). Key points:(1) AUS: Rev +4.3% on improved indexation and private volume growth, but -40bps EBIT margin decline; (2) UK Hosp: ",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "383d03f0d96d75f0",
        "value": 0.11900000000000001,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "on improved indexation and private volume growth, but -40bps EBIT margin decline; (2) UK Hosp: Rev +11.9%, volume growth/ mix and operational efficiencies drove +70bps EBIT margin; (3) Elysium: weakne",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "60964f1800b672a3",
        "value": 0.042,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "C expects FY26 EBIT growth The usual positive vibes from AUS were absent today with 2H25 EBIT down 4.2% as public hospitals, QLD weather, and digital and data spend dragged on earnings. Despite contin",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "b47cc2a3a16e9eba",
        "value": 0.02,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "s FY26 EBIT growth supported by private hospital activity recovery. We forecast modest EBIT growth (+2%) given Peel contract loss and lower Jondalup pricing. RHC aims to keep digital, and data spend f",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "3342b4d4d7f5ca5a",
        "value": 0.005,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "sion time frame. Margin expansion remains difficult given French Government funding cuts and modest 0.5% Mar25 tariff increase. <table><tr><td>Estimates (Jun) (A$)</td><td></td><td>2024A</td><td>2025A",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "95750ce879b0ba30",
        "value": -0.10800000000000001,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "</td><td></td><td>1.61</td><td>1.98</td><td>2.34</td></tr><tr><td>EPS Change (YoY)</td><td></td><td>-10.8%</td><td>-97.3%</td><td>NM</td><td>51.4%</td><td>29.4%</td></tr><tr><td>Dividend/ Share</td><t",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "938030044ff55f63",
        "value": -0.973,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td>1.61</td><td>1.98</td><td>2.34</td></tr><tr><td>EPS Change (YoY)</td><td></td><td>-10.8%</td><td>-97.3%</td><td>NM</td><td>51.4%</td><td>29.4%</td></tr><tr><td>Dividend/ Share</td><td></td><td>0.65",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "f4c8fa5b60c93ab3",
        "value": 0.514,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td>2.34</td></tr><tr><td>EPS Change (YoY)</td><td></td><td>-10.8%</td><td>-97.3%</td><td>NM</td><td>51.4%</td><td>29.4%</td></tr><tr><td>Dividend/ Share</td><td></td><td>0.650</td><td>0.800</td><td>0.",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "2c0c39c4460d9fff",
        "value": 0.294,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "tr><tr><td>EPS Change (YoY)</td><td></td><td>-10.8%</td><td>-97.3%</td><td>NM</td><td>51.4%</td><td>29.4%</td></tr><tr><td>Dividend/ Share</td><td></td><td>0.650</td><td>0.800</td><td>0.938</td><td>1.",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "8d449c52ba26a772",
        "value": 0.0191,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "3.04x</td><td>26.55x</td><td>17.53x</td><td>13.55x</td></tr><tr><td>Dividend Yield</td><td></td><td>1.91%</td><td>2.35%</td><td>2.75%</td><td>3.09%</td><td>4.27%</td></tr><tr><td>EV/ EBITDA*</td><td><",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "bb243c377e1d4d76",
        "value": 0.0235,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "26.55x</td><td>17.53x</td><td>13.55x</td></tr><tr><td>Dividend Yield</td><td></td><td>1.91%</td><td>2.35%</td><td>2.75%</td><td>3.09%</td><td>4.27%</td></tr><tr><td>EV/ EBITDA*</td><td></td><td>6.27x<",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "4bf459c8dad93b6c",
        "value": 0.0275,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ">17.53x</td><td>13.55x</td></tr><tr><td>Dividend Yield</td><td></td><td>1.91%</td><td>2.35%</td><td>2.75%</td><td>3.09%</td><td>4.27%</td></tr><tr><td>EV/ EBITDA*</td><td></td><td>6.27x</td><td>6.40x<",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "1d5aa15df74949b0",
        "value": 0.030899999999999997,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d>13.55x</td></tr><tr><td>Dividend Yield</td><td></td><td>1.91%</td><td>2.35%</td><td>2.75%</td><td>3.09%</td><td>4.27%</td></tr><tr><td>EV/ EBITDA*</td><td></td><td>6.27x</td><td>6.40x</td><td>5.96x<",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "1a989ec471f2af7a",
        "value": 0.042699999999999995,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "/tr><tr><td>Dividend Yield</td><td></td><td>1.91%</td><td>2.35%</td><td>2.75%</td><td>3.09%</td><td>4.27%</td></tr><tr><td>EV/ EBITDA*</td><td></td><td>6.27x</td><td>6.40x</td><td>5.96x</td><td>5.35x<",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "2f24b8c0ba741cdd",
        "value": -0.25980000000000003,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "0x</td><td>5.96x</td><td>5.35x</td><td>4.93x</td></tr><tr><td>Free Cash Flow/Tetd*</td><td></td><td>-25.98%</td><td>8.95%</td><td>10.05%</td><td>11.68%</td><td>11.87%</td></tr></table> * For full defi",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "e555ff1961801c45",
        "value": 0.0895,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "</td><td>5.35x</td><td>4.93x</td></tr><tr><td>Free Cash Flow/Tetd*</td><td></td><td>-25.98%</td><td>8.95%</td><td>10.05%</td><td>11.68%</td><td>11.87%</td></tr></table> * For full definitions of Qmeth",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "4d8dac4ecb12fb3b",
        "value": 0.1005,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "</td><td>4.93x</td></tr><tr><td>Free Cash Flow/Tetd*</td><td></td><td>-25.98%</td><td>8.95%</td><td>10.05%</td><td>11.68%</td><td>11.87%</td></tr></table> * For full definitions of Qmethod™ measures, ",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "bfc170f4ead1e2a4",
        "value": 0.1168,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "/td></tr><tr><td>Free Cash Flow/Tetd*</td><td></td><td>-25.98%</td><td>8.95%</td><td>10.05%</td><td>11.68%</td><td>11.87%</td></tr></table> * For full definitions of Qmethod™ measures, see page 8. &gt",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "261d13ab74f7e2ff",
        "value": 0.11869999999999999,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d>Free Cash Flow/Tetd*</td><td></td><td>-25.98%</td><td>8.95%</td><td>10.05%</td><td>11.68%</td><td>11.87%</td></tr></table> * For full definitions of Qmethod™ measures, see page 8. &gt;&gt; Employed ",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "1a02cc212f18f86a",
        "value": 0.784,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "e Daily Value (mn)</td><td></td><td>13.10 USD</td><td></td></tr><tr><td>Free Float</td><td></td><td>78.4%</td><td></td></tr><tr><td>BofA Ticker / Exchange</td><td></td><td>RMSYF / ASX</td><td></td></t",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "b32a9086db9854ee",
        "value": 0.064,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "g / Reuters</td><td></td><td>RHC AU / RHC AX</td><td></td></tr><tr><td>ROE (2026E)</td><td></td><td>6.4%</td><td></td></tr><tr><td>Net Dbt to Eqty (Jun-2025A)</td><td></td><td>83.3%</td><td></td></tr>",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "6c24ecbf1770f78e",
        "value": 0.833,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "2026E)</td><td></td><td>6.4%</td><td></td></tr><tr><td>Net Dbt to Eqty (Jun-2025A)</td><td></td><td>83.3%</td><td></td></tr></table> # Glossary NHS: National Health Service PHI: Private Health Insurer",
        "provenance": {
          "page": 0
        }
      },
      {
        "num_id": "fc8c8643eb7ab568",
        "value": 0.04,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "e*</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Return on Capital Employed</td><td>4.0%</td><td>5.2%</td><td>4.2%</td><td>5.1%</td><td>5.8%</td></tr><tr><td>Return on Equity</td><td>5",
        "provenance": {
          "page": 1
        }
      },
      {
        "num_id": "fc2aa18b5edae29a",
        "value": 0.052000000000000005,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td><td></td><td></td><td></td><td></td></tr><tr><td>Return on Capital Employed</td><td>4.0%</td><td>5.2%</td><td>4.2%</td><td>5.1%</td><td>5.8%</td></tr><tr><td>Return on Equity</td><td>5.9%</td><td>0",
        "provenance": {
          "page": 1
        }
      },
      {
        "num_id": "c611f1fcd07af702",
        "value": 0.042,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td></td><td></td><td></td></tr><tr><td>Return on Capital Employed</td><td>4.0%</td><td>5.2%</td><td>4.2%</td><td>5.1%</td><td>5.8%</td></tr><tr><td>Return on Equity</td><td>5.9%</td><td>0.1%</td><td>6",
        "provenance": {
          "page": 1
        }
      },
      {
        "num_id": "456f68c863b4b631",
        "value": 0.051,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "/td><td></td></tr><tr><td>Return on Capital Employed</td><td>4.0%</td><td>5.2%</td><td>4.2%</td><td>5.1%</td><td>5.8%</td></tr><tr><td>Return on Equity</td><td>5.9%</td><td>0.1%</td><td>6.4%</td><td>9",
        "provenance": {
          "page": 1
        }
      },
      {
        "num_id": "8fe72fa18c9bf94b",
        "value": 0.057999999999999996,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "</tr><tr><td>Return on Capital Employed</td><td>4.0%</td><td>5.2%</td><td>4.2%</td><td>5.1%</td><td>5.8%</td></tr><tr><td>Return on Equity</td><td>5.9%</td><td>0.1%</td><td>6.4%</td><td>9.3%</td><td>1",
        "provenance": {
          "page": 1
        }
      },
      {
        "num_id": "1a71bb553f4bdea2",
        "value": 0.059000000000000004,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ">4.0%</td><td>5.2%</td><td>4.2%</td><td>5.1%</td><td>5.8%</td></tr><tr><td>Return on Equity</td><td>5.9%</td><td>0.1%</td><td>6.4%</td><td>9.3%</td><td>11.4%</td></tr><tr><td>Operating Margin</td><td>",
        "provenance": {
          "page": 1
        }
      },
      {
        "num_id": "31ac067eca18da2c",
        "value": 0.001,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ">5.2%</td><td>4.2%</td><td>5.1%</td><td>5.8%</td></tr><tr><td>Return on Equity</td><td>5.9%</td><td>0.1%</td><td>6.4%</td><td>9.3%</td><td>11.4%</td></tr><tr><td>Operating Margin</td><td>6.0%</td><td>",
        "provenance": {
          "page": 1
        }
      },
      {
        "num_id": "9dd4eebf266889aa",
        "value": 0.064,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ">4.2%</td><td>5.1%</td><td>5.8%</td></tr><tr><td>Return on Equity</td><td>5.9%</td><td>0.1%</td><td>6.4%</td><td>9.3%</td><td>11.4%</td></tr><tr><td>Operating Margin</td><td>6.0%</td><td>5.8%</td><td>",
        "provenance": {
          "page": 1
        }
      },
      {
        "num_id": "6975e5b7ba03bd90",
        "value": 0.09300000000000001,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ">5.1%</td><td>5.8%</td></tr><tr><td>Return on Equity</td><td>5.9%</td><td>0.1%</td><td>6.4%</td><td>9.3%</td><td>11.4%</td></tr><tr><td>Operating Margin</td><td>6.0%</td><td>5.8%</td><td>5.8%</td><td>",
        "provenance": {
          "page": 1
        }
      },
      {
        "num_id": "1ff751731df36548",
        "value": 0.114,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ">5.8%</td></tr><tr><td>Return on Equity</td><td>5.9%</td><td>0.1%</td><td>6.4%</td><td>9.3%</td><td>11.4%</td></tr><tr><td>Operating Margin</td><td>6.0%</td><td>5.8%</td><td>5.8%</td><td>6.6%</td><td>",
        "provenance": {
          "page": 1
        }
      },
      {
        "num_id": "61402930bb1883ef",
        "value": 0.06,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "5.9%</td><td>0.1%</td><td>6.4%</td><td>9.3%</td><td>11.4%</td></tr><tr><td>Operating Margin</td><td>6.0%</td><td>5.8%</td><td>5.8%</td><td>6.6%</td><td>7.4%</td></tr><tr><td>EBITDA Margin</td><td>12.7",
        "provenance": {
          "page": 1
        }
      },
      {
        "num_id": "8b6b58c38c73b9e9",
        "value": 0.057999999999999996,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "0.1%</td><td>6.4%</td><td>9.3%</td><td>11.4%</td></tr><tr><td>Operating Margin</td><td>6.0%</td><td>5.8%</td><td>5.8%</td><td>6.6%</td><td>7.4%</td></tr><tr><td>EBITDA Margin</td><td>12.7%</td><td>12.",
        "provenance": {
          "page": 1
        }
      },
      {
        "num_id": "1482c40bfaaec287",
        "value": 0.057999999999999996,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "6.4%</td><td>9.3%</td><td>11.4%</td></tr><tr><td>Operating Margin</td><td>6.0%</td><td>5.8%</td><td>5.8%</td><td>6.6%</td><td>7.4%</td></tr><tr><td>EBITDA Margin</td><td>12.7%</td><td>12.1%</td><td>12",
        "provenance": {
          "page": 1
        }
      },
      {
        "num_id": "070cf0efae599115",
        "value": 0.066,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "9.3%</td><td>11.4%</td></tr><tr><td>Operating Margin</td><td>6.0%</td><td>5.8%</td><td>5.8%</td><td>6.6%</td><td>7.4%</td></tr><tr><td>EBITDA Margin</td><td>12.7%</td><td>12.1%</td><td>12.4%</td><td>1",
        "provenance": {
          "page": 1
        }
      },
      {
        "num_id": "95bef99b6902b136",
        "value": 0.07400000000000001,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "11.4%</td></tr><tr><td>Operating Margin</td><td>6.0%</td><td>5.8%</td><td>5.8%</td><td>6.6%</td><td>7.4%</td></tr><tr><td>EBITDA Margin</td><td>12.7%</td><td>12.1%</td><td>12.4%</td><td>13.2%</td><td>",
        "provenance": {
          "page": 1
        }
      },
      {
        "num_id": "c188581b59a2a14d",
        "value": 0.127,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "<td>6.0%</td><td>5.8%</td><td>5.8%</td><td>6.6%</td><td>7.4%</td></tr><tr><td>EBITDA Margin</td><td>12.7%</td><td>12.1%</td><td>12.4%</td><td>13.2%</td><td>13.9%</td></tr><tr><td>iQmethod™ - Quality o",
        "provenance": {
          "page": 1
        }
      },
      {
        "num_id": "78bfdc74839796a5",
        "value": 0.121,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td>5.8%</td><td>5.8%</td><td>6.6%</td><td>7.4%</td></tr><tr><td>EBITDA Margin</td><td>12.7%</td><td>12.1%</td><td>12.4%</td><td>13.2%</td><td>13.9%</td></tr><tr><td>iQmethod™ - Quality of Earnings*</t",
        "provenance": {
          "page": 1
        }
      },
      {
        "num_id": "5b0be4db3458d716",
        "value": 0.124,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d>5.8%</td><td>6.6%</td><td>7.4%</td></tr><tr><td>EBITDA Margin</td><td>12.7%</td><td>12.1%</td><td>12.4%</td><td>13.2%</td><td>13.9%</td></tr><tr><td>iQmethod™ - Quality of Earnings*</td><td></td><td",
        "provenance": {
          "page": 1
        }
      },
      {
        "num_id": "980e697707e655a3",
        "value": 0.132,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ">6.6%</td><td>7.4%</td></tr><tr><td>EBITDA Margin</td><td>12.7%</td><td>12.1%</td><td>12.4%</td><td>13.2%</td><td>13.9%</td></tr><tr><td>iQmethod™ - Quality of Earnings*</td><td></td><td></td><td></td",
        "provenance": {
          "page": 1
        }
      },
      {
        "num_id": "b44eb383fb7256e1",
        "value": 0.139,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "7.4%</td></tr><tr><td>EBITDA Margin</td><td>12.7%</td><td>12.1%</td><td>12.4%</td><td>13.2%</td><td>13.9%</td></tr><tr><td>iQmethod™ - Quality of Earnings*</td><td></td><td></td><td></td><td></td><td>",
        "provenance": {
          "page": 1
        }
      },
      {
        "num_id": "90fd4620a1522217",
        "value": 0.583,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td><td>217.8x</td><td>5.4x</td><td>4.3x</td><td>3.4x</td></tr><tr><td>Dividend Payout Ratio</td><td>58.3%</td><td>2,705.9%</td><td>73.0%</td><td>54.1%</td><td>57.8%</td></tr><tr><td>Tax Rate (Reported",
        "provenance": {
          "page": 1
        }
      },
      {
        "num_id": "f81b379d4c1ee2ab",
        "value": 7.059,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d><td>5.4x</td><td>4.3x</td><td>3.4x</td></tr><tr><td>Dividend Payout Ratio</td><td>58.3%</td><td>2,705.9%</td><td>73.0%</td><td>54.1%</td><td>57.8%</td></tr><tr><td>Tax Rate (Reported)</td><td>31.5%<",
        "provenance": {
          "page": 1
        }
      },
      {
        "num_id": "2ecfc1f80e793d2b",
        "value": 0.73,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "<td>4.3x</td><td>3.4x</td></tr><tr><td>Dividend Payout Ratio</td><td>58.3%</td><td>2,705.9%</td><td>73.0%</td><td>54.1%</td><td>57.8%</td></tr><tr><td>Tax Rate (Reported)</td><td>31.5%</td><td>12.9%</",
        "provenance": {
          "page": 1
        }
      },
      {
        "num_id": "bb33f25f1bc2b1f8",
        "value": 0.541,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td>3.4x</td></tr><tr><td>Dividend Payout Ratio</td><td>58.3%</td><td>2,705.9%</td><td>73.0%</td><td>54.1%</td><td>57.8%</td></tr><tr><td>Tax Rate (Reported)</td><td>31.5%</td><td>12.9%</td><td>33.0%</",
        "provenance": {
          "page": 1
        }
      },
      {
        "num_id": "754c32762a2e9a1e",
        "value": 0.578,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "tr><tr><td>Dividend Payout Ratio</td><td>58.3%</td><td>2,705.9%</td><td>73.0%</td><td>54.1%</td><td>57.8%</td></tr><tr><td>Tax Rate (Reported)</td><td>31.5%</td><td>12.9%</td><td>33.0%</td><td>32.0%</",
        "provenance": {
          "page": 1
        }
      },
      {
        "num_id": "d177d3145cbc98f6",
        "value": 0.315,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "<td>2,705.9%</td><td>73.0%</td><td>54.1%</td><td>57.8%</td></tr><tr><td>Tax Rate (Reported)</td><td>31.5%</td><td>12.9%</td><td>33.0%</td><td>32.0%</td><td>32.0%</td></tr><tr><td>Net Debt-to-Equity Ra",
        "provenance": {
          "page": 1
        }
      },
      {
        "num_id": "ef0c0bfd5b6c9846",
        "value": 0.129,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td><td>73.0%</td><td>54.1%</td><td>57.8%</td></tr><tr><td>Tax Rate (Reported)</td><td>31.5%</td><td>12.9%</td><td>33.0%</td><td>32.0%</td><td>32.0%</td></tr><tr><td>Net Debt-to-Equity Ratio</td><td>80",
        "provenance": {
          "page": 1
        }
      },
      {
        "num_id": "8e2156fe69a79c9d",
        "value": 0.33,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td><td>54.1%</td><td>57.8%</td></tr><tr><td>Tax Rate (Reported)</td><td>31.5%</td><td>12.9%</td><td>33.0%</td><td>32.0%</td><td>32.0%</td></tr><tr><td>Net Debt-to-Equity Ratio</td><td>80.0%</td><td>83",
        "provenance": {
          "page": 1
        }
      },
      {
        "num_id": "2dba740c995fc5ef",
        "value": 0.32,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td><td>57.8%</td></tr><tr><td>Tax Rate (Reported)</td><td>31.5%</td><td>12.9%</td><td>33.0%</td><td>32.0%</td><td>32.0%</td></tr><tr><td>Net Debt-to-Equity Ratio</td><td>80.0%</td><td>83.3%</td><td>82",
        "provenance": {
          "page": 1
        }
      },
      {
        "num_id": "abf1867f70dc9d54",
        "value": 0.32,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td></tr><tr><td>Tax Rate (Reported)</td><td>31.5%</td><td>12.9%</td><td>33.0%</td><td>32.0%</td><td>32.0%</td></tr><tr><td>Net Debt-to-Equity Ratio</td><td>80.0%</td><td>83.3%</td><td>82.0%</td><td>77",
        "provenance": {
          "page": 1
        }
      },
      {
        "num_id": "663fcc39918e512e",
        "value": 0.8,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d>12.9%</td><td>33.0%</td><td>32.0%</td><td>32.0%</td></tr><tr><td>Net Debt-to-Equity Ratio</td><td>80.0%</td><td>83.3%</td><td>82.0%</td><td>77.4%</td><td>73.8%</td></tr><tr><td>Interest Cover</td><t",
        "provenance": {
          "page": 1
        }
      },
      {
        "num_id": "bf8fa567387baa89",
        "value": 0.833,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d>33.0%</td><td>32.0%</td><td>32.0%</td></tr><tr><td>Net Debt-to-Equity Ratio</td><td>80.0%</td><td>83.3%</td><td>82.0%</td><td>77.4%</td><td>73.8%</td></tr><tr><td>Interest Cover</td><td>1.6x</td><td",
        "provenance": {
          "page": 1
        }
      },
      {
        "num_id": "5cdfbea7d3e2c292",
        "value": 0.82,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d>32.0%</td><td>32.0%</td></tr><tr><td>Net Debt-to-Equity Ratio</td><td>80.0%</td><td>83.3%</td><td>82.0%</td><td>77.4%</td><td>73.8%</td></tr><tr><td>Interest Cover</td><td>1.6x</td><td>1.7x</td><td>",
        "provenance": {
          "page": 1
        }
      },
      {
        "num_id": "389e9dc52a9f4ba0",
        "value": 0.774,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d>32.0%</td></tr><tr><td>Net Debt-to-Equity Ratio</td><td>80.0%</td><td>83.3%</td><td>82.0%</td><td>77.4%</td><td>73.8%</td></tr><tr><td>Interest Cover</td><td>1.6x</td><td>1.7x</td><td>1.8x</td><td>2",
        "provenance": {
          "page": 1
        }
      },
      {
        "num_id": "cc19c50773978628",
        "value": 0.738,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "tr><tr><td>Net Debt-to-Equity Ratio</td><td>80.0%</td><td>83.3%</td><td>82.0%</td><td>77.4%</td><td>73.8%</td></tr><tr><td>Interest Cover</td><td>1.6x</td><td>1.7x</td><td>1.8x</td><td>2.3x</td><td>2.",
        "provenance": {
          "page": 1
        }
      },
      {
        "num_id": "7ec0f6d1fa9b11af",
        "value": 1.0,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "><tr><td>Key Metrics</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Franking</td><td>100%</td><td>100%</td><td>100%</td><td>100%</td><td>100%</td></tr></table> \\\\* For full definitions ",
        "provenance": {
          "page": 1
        }
      },
      {
        "num_id": "703b87365c3c64f0",
        "value": 1.0,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "Metrics</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Franking</td><td>100%</td><td>100%</td><td>100%</td><td>100%</td><td>100%</td></tr></table> \\\\* For full definitions of iQmethod m",
        "provenance": {
          "page": 1
        }
      },
      {
        "num_id": "d18e5fdedb3d550d",
        "value": 1.0,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td></td><td></td><td></td><td></td><td></td></tr><tr><td>Franking</td><td>100%</td><td>100%</td><td>100%</td><td>100%</td><td>100%</td></tr></table> \\\\* For full definitions of iQmethod measures, see ",
        "provenance": {
          "page": 1
        }
      },
      {
        "num_id": "5e9d405604a19d01",
        "value": 1.0,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "/td><td></td><td></td><td></td></tr><tr><td>Franking</td><td>100%</td><td>100%</td><td>100%</td><td>100%</td><td>100%</td></tr></table> \\\\* For full definitions of iQmethod measures, see page 8.<｜end▁",
        "provenance": {
          "page": 1
        }
      },
      {
        "num_id": "2c6642608d4dc9de",
        "value": 1.0,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "<td></td><td></td></tr><tr><td>Franking</td><td>100%</td><td>100%</td><td>100%</td><td>100%</td><td>100%</td></tr></table> \\\\* For full definitions of iQmethod measures, see page 8.<｜end▁of▁sentence｜>",
        "provenance": {
          "page": 1
        }
      },
      {
        "num_id": "b4f27115db261ff0",
        "value": 53.0,
        "unit": "€",
        "metric_type": "currency",
        "context": "or Sante regarding private hospital funding and political outlook. FY25 earnings were impacted by a €53 decline in funding. Despite a reduction in general cost inflation, significant potential wage in",
        "provenance": {
          "page": 2
        }
      },
      {
        "num_id": "14b7c0e0adfde7dd",
        "value": 24.0,
        "unit": "€",
        "metric_type": "currency",
        "context": "pressure in France remains. RHC displayed capital discipline in FY25 reducing Europe capex spend by €24m. ## No line of sight to Sante exit RHC commented they are working through the options of the Sa",
        "provenance": {
          "page": 2
        }
      },
      {
        "num_id": "cae054ca8f2f69c1",
        "value": 0.06,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td>FY25E</td><td>Diff (%)</td></tr><tr><td>Revenue</td><td>$m</td><td>16,770</td><td>17,839</td><td>6%</td><td>17,586</td><td>1%</td><td>17,831</td><td>0%</td></tr><tr><td>EBITDA</td><td>$m</td><td>2,",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "9ed336caeb482609",
        "value": 0.01,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "/td></tr><tr><td>Revenue</td><td>$m</td><td>16,770</td><td>17,839</td><td>6%</td><td>17,586</td><td>1%</td><td>17,831</td><td>0%</td></tr><tr><td>EBITDA</td><td>$m</td><td>2,112</td><td>2,169</td><td>",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "0151994443888372",
        "value": 0.0,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td><td>$m</td><td>16,770</td><td>17,839</td><td>6%</td><td>17,586</td><td>1%</td><td>17,831</td><td>0%</td></tr><tr><td>EBITDA</td><td>$m</td><td>2,112</td><td>2,169</td><td>3%</td><td>2,185</td><td>-",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "4a7dc44e7f90ce98",
        "value": 0.03,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "1%</td><td>17,831</td><td>0%</td></tr><tr><td>EBITDA</td><td>$m</td><td>2,112</td><td>2,169</td><td>3%</td><td>2,185</td><td>-1%</td><td>2,192</td><td>-1%</td></tr><tr><td>EBIT</td><td>$m</td><td>1,03",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "c7585c366fa43cf9",
        "value": -0.01,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ">0%</td></tr><tr><td>EBITDA</td><td>$m</td><td>2,112</td><td>2,169</td><td>3%</td><td>2,185</td><td>-1%</td><td>2,192</td><td>-1%</td></tr><tr><td>EBIT</td><td>$m</td><td>1,034</td><td>1,043</td><td>1",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "053b068ba6dd6568",
        "value": -0.01,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "A</td><td>$m</td><td>2,112</td><td>2,169</td><td>3%</td><td>2,185</td><td>-1%</td><td>2,192</td><td>-1%</td></tr><tr><td>EBIT</td><td>$m</td><td>1,034</td><td>1,043</td><td>1%</td><td>1,083</td><td>-4",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "445e93c5fcbe1d69",
        "value": 0.01,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ">-1%</td><td>2,192</td><td>-1%</td></tr><tr><td>EBIT</td><td>$m</td><td>1,034</td><td>1,043</td><td>1%</td><td>1,083</td><td>-4%</td><td>1,030</td><td>1%</td></tr><tr><td>NPAT (to owners parent)</td><",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "761ef1779ab9bece",
        "value": -0.04,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d>-1%</td></tr><tr><td>EBIT</td><td>$m</td><td>1,034</td><td>1,043</td><td>1%</td><td>1,083</td><td>-4%</td><td>1,030</td><td>1%</td></tr><tr><td>NPAT (to owners parent)</td><td>$m</td><td>300</td><td",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "73e8eb6d5435f3a4",
        "value": 0.01,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "T</td><td>$m</td><td>1,034</td><td>1,043</td><td>1%</td><td>1,083</td><td>-4%</td><td>1,030</td><td>1%</td></tr><tr><td>NPAT (to owners parent)</td><td>$m</td><td>300</td><td>305</td><td>2%</td><td>30",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "6bccd86d3dca6027",
        "value": 0.02,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ",030</td><td>1%</td></tr><tr><td>NPAT (to owners parent)</td><td>$m</td><td>300</td><td>305</td><td>2%</td><td>301</td><td>1%</td><td>300</td><td>2%</td></tr><tr><td>Pre share metrics</td><td></td><td",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "2118bc6757deea2b",
        "value": 0.01,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "r><tr><td>NPAT (to owners parent)</td><td>$m</td><td>300</td><td>305</td><td>2%</td><td>301</td><td>1%</td><td>300</td><td>2%</td></tr><tr><td>Pre share metrics</td><td></td><td>FY24A</td><td>FY25E</t",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "1a9c213577898aaf",
        "value": 0.02,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "rs parent)</td><td>$m</td><td>300</td><td>305</td><td>2%</td><td>301</td><td>1%</td><td>300</td><td>2%</td></tr><tr><td>Pre share metrics</td><td></td><td>FY24A</td><td>FY25E</td><td></td><td>FY25E</t",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "98b883b4f5ce9885",
        "value": 0.12,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "/td></tr><tr><td>EPS (post CARES dividend, diluted)</td><td>$/shr</td><td>1.11</td><td>1.25</td><td>12%</td><td>1.25</td><td>0%</td><td>1.23</td><td>2%</td></tr><tr><td>DPS</td><td>$/shr</td><td>0.65<",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "5a79cb0f7d2be45c",
        "value": 0.0,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "t CARES dividend, diluted)</td><td>$/shr</td><td>1.11</td><td>1.25</td><td>12%</td><td>1.25</td><td>0%</td><td>1.23</td><td>2%</td></tr><tr><td>DPS</td><td>$/shr</td><td>0.65</td><td>0.80</td><td>23%<",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "83555fe755f6567e",
        "value": 0.02,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d)</td><td>$/shr</td><td>1.11</td><td>1.25</td><td>12%</td><td>1.25</td><td>0%</td><td>1.23</td><td>2%</td></tr><tr><td>DPS</td><td>$/shr</td><td>0.65</td><td>0.80</td><td>23%</td><td>0.74</td><td>9%<",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "9fb32e86a4b2e734",
        "value": 0.23,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "<td>0%</td><td>1.23</td><td>2%</td></tr><tr><td>DPS</td><td>$/shr</td><td>0.65</td><td>0.80</td><td>23%</td><td>0.74</td><td>9%</td><td>0.8</td><td>-1%</td></tr><tr><td>Analysis</td><td></td><td>FY24A",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "3d25dd17995e8c5b",
        "value": 0.09,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td>2%</td></tr><tr><td>DPS</td><td>$/shr</td><td>0.65</td><td>0.80</td><td>23%</td><td>0.74</td><td>9%</td><td>0.8</td><td>-1%</td></tr><tr><td>Analysis</td><td></td><td>FY24A</td><td>FY25E</td><td>pp",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "fa36288487f291ce",
        "value": -0.01,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "DPS</td><td>$/shr</td><td>0.65</td><td>0.80</td><td>23%</td><td>0.74</td><td>9%</td><td>0.8</td><td>-1%</td></tr><tr><td>Analysis</td><td></td><td>FY24A</td><td>FY25E</td><td>ppts</td><td>FY25E</td><t",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "e26069f94d9ca80a",
        "value": 0.126,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "><td>FY25E</td><td>ppts</td><td>FY25E</td><td>ppts</td></tr><tr><td>EBITDA margin</td><td>%</td><td>12.6%</td><td>12.2%</td><td>-0.4</td><td>12.4%</td><td>-0.3</td><td>12.3%</td><td>-0.1</td></tr><tr>",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "ffdd6351561dc96b",
        "value": 0.122,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "><td>ppts</td><td>FY25E</td><td>ppts</td></tr><tr><td>EBITDA margin</td><td>%</td><td>12.6%</td><td>12.2%</td><td>-0.4</td><td>12.4%</td><td>-0.3</td><td>12.3%</td><td>-0.1</td></tr><tr><td>EBIT margi",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "937b90bc20ddeeea",
        "value": 0.124,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "><td>ppts</td></tr><tr><td>EBITDA margin</td><td>%</td><td>12.6%</td><td>12.2%</td><td>-0.4</td><td>12.4%</td><td>-0.3</td><td>12.3%</td><td>-0.1</td></tr><tr><td>EBIT margin</td><td>%</td><td>6.2%</t",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "1a22c2598a0e3f00",
        "value": 0.12300000000000001,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "EBITDA margin</td><td>%</td><td>12.6%</td><td>12.2%</td><td>-0.4</td><td>12.4%</td><td>-0.3</td><td>12.3%</td><td>-0.1</td></tr><tr><td>EBIT margin</td><td>%</td><td>6.2%</td><td>5.8%</td><td>-0.3</td",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "a188029cc463446a",
        "value": 0.062,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td><td>12.4%</td><td>-0.3</td><td>12.3%</td><td>-0.1</td></tr><tr><td>EBIT margin</td><td>%</td><td>6.2%</td><td>5.8%</td><td>-0.3</td><td>6.2%</td><td>-0.3</td><td>5.8%</td><td>0.1</td></tr><tr><td>N",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "ba12babf6b97ea4c",
        "value": 0.057999999999999996,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "/td><td>-0.3</td><td>12.3%</td><td>-0.1</td></tr><tr><td>EBIT margin</td><td>%</td><td>6.2%</td><td>5.8%</td><td>-0.3</td><td>6.2%</td><td>-0.3</td><td>5.8%</td><td>0.1</td></tr><tr><td>NPAT margin</t",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "1321758d4b9d8fe8",
        "value": 0.062,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "</td><td>-0.1</td></tr><tr><td>EBIT margin</td><td>%</td><td>6.2%</td><td>5.8%</td><td>-0.3</td><td>6.2%</td><td>-0.3</td><td>5.8%</td><td>0.1</td></tr><tr><td>NPAT margin</td><td>%</td><td>1.8%</td><",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "cefb8a689fc7cd4a",
        "value": 0.057999999999999996,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "><td>EBIT margin</td><td>%</td><td>6.2%</td><td>5.8%</td><td>-0.3</td><td>6.2%</td><td>-0.3</td><td>5.8%</td><td>0.1</td></tr><tr><td>NPAT margin</td><td>%</td><td>1.8%</td><td>1.7%</td><td>-0.1</td><",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "c4e2dbb547510839",
        "value": 0.018000000000000002,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "3</td><td>6.2%</td><td>-0.3</td><td>5.8%</td><td>0.1</td></tr><tr><td>NPAT margin</td><td>%</td><td>1.8%</td><td>1.7%</td><td>-0.1</td><td>1.7%</td><td>0.0</td><td>1.7%</td><td>0.0</td></tr></table> S",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "1403271538ee3059",
        "value": 0.017,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "%</td><td>-0.3</td><td>5.8%</td><td>0.1</td></tr><tr><td>NPAT margin</td><td>%</td><td>1.8%</td><td>1.7%</td><td>-0.1</td><td>1.7%</td><td>0.0</td><td>1.7%</td><td>0.0</td></tr></table> Source: BofA G",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "48f80fa7a859cda7",
        "value": 0.017,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "%</td><td>0.1</td></tr><tr><td>NPAT margin</td><td>%</td><td>1.8%</td><td>1.7%</td><td>-0.1</td><td>1.7%</td><td>0.0</td><td>1.7%</td><td>0.0</td></tr></table> Source: BofA Global Research estimates<｜",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "4031a3e5a4abad25",
        "value": 0.017,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "r><td>NPAT margin</td><td>%</td><td>1.8%</td><td>1.7%</td><td>-0.1</td><td>1.7%</td><td>0.0</td><td>1.7%</td><td>0.0</td></tr></table> Source: BofA Global Research estimates<｜end▁of▁sentence｜>",
        "provenance": {
          "page": 3
        }
      },
      {
        "num_id": "f6470157afd0db9d",
        "value": 0.025,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d><td>Old</td><td>Ch&gt;%</td></tr><tr><td>Revenue</td><td>Sm</td><td>18,778</td><td>18,329</td><td>2.5%</td><td>19,583</td><td>19,094</td><td>2.6%</td><td>20,088</td><td>19,587</td><td>2.6%</td></tr>",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "ecde117bb65ffbcc",
        "value": 0.026000000000000002,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "Revenue</td><td>Sm</td><td>18,778</td><td>18,329</td><td>2.5%</td><td>19,583</td><td>19,094</td><td>2.6%</td><td>20,088</td><td>19,587</td><td>2.6%</td></tr><tr><td>EBITDA</td><td>Sm</td><td>2,325</td",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "881df17e807144d1",
        "value": 0.026000000000000002,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "8,329</td><td>2.5%</td><td>19,583</td><td>19,094</td><td>2.6%</td><td>20,088</td><td>19,587</td><td>2.6%</td></tr><tr><td>EBITDA</td><td>Sm</td><td>2,325</td><td>2,358</td><td>-1.4%</td><td>2,577</td>",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "ec58343f6556fbdb",
        "value": -0.013999999999999999,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "</td><td>19,587</td><td>2.6%</td></tr><tr><td>EBITDA</td><td>Sm</td><td>2,325</td><td>2,358</td><td>-1.4%</td><td>2,577</td><td>2,572</td><td>0.2%</td><td>2,799</td><td>2,732</td><td>2.5%</td></tr><tr",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "3d1d0cef26ea60b1",
        "value": 0.002,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "<td>EBITDA</td><td>Sm</td><td>2,325</td><td>2,358</td><td>-1.4%</td><td>2,577</td><td>2,572</td><td>0.2%</td><td>2,799</td><td>2,732</td><td>2.5%</td></tr><tr><td>EBIT</td><td>Sm</td><td>1,096</td><td",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "a622f5b11919e358",
        "value": 0.025,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "td>2,358</td><td>-1.4%</td><td>2,577</td><td>2,572</td><td>0.2%</td><td>2,799</td><td>2,732</td><td>2.5%</td></tr><tr><td>EBIT</td><td>Sm</td><td>1,096</td><td>1,213</td><td>-9.7%</td><td>1,296</td><t",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "fa6b99cf9e42b42d",
        "value": -0.09699999999999999,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "799</td><td>2,732</td><td>2.5%</td></tr><tr><td>EBIT</td><td>Sm</td><td>1,096</td><td>1,213</td><td>-9.7%</td><td>1,296</td><td>1,342</td><td>-3.4%</td><td>1,487</td><td>1,471</td><td>1.1%</td></tr><t",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "cda1eb5d82766589",
        "value": -0.034,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "r><td>EBIT</td><td>Sm</td><td>1,096</td><td>1,213</td><td>-9.7%</td><td>1,296</td><td>1,342</td><td>-3.4%</td><td>1,487</td><td>1,471</td><td>1.1%</td></tr><tr><td>Underlying NPAT</td><td>Sm</td><td>3",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "52f3519332e2cb56",
        "value": 0.011000000000000001,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d>1,213</td><td>-9.7%</td><td>1,296</td><td>1,342</td><td>-3.4%</td><td>1,487</td><td>1,471</td><td>1.1%</td></tr><tr><td>Underlying NPAT</td><td>Sm</td><td>338</td><td>420</td><td>-19.5%</td><td>500<",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "1ff850950fd19f47",
        "value": -0.195,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "><td>1,471</td><td>1.1%</td></tr><tr><td>Underlying NPAT</td><td>Sm</td><td>338</td><td>420</td><td>-19.5%</td><td>500</td><td>558</td><td>-10.4%</td><td>643</td><td>657</td><td>-2.2%</td></tr><tr><td",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "6a1b6a319794f26c",
        "value": -0.10400000000000001,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d>Underlying NPAT</td><td>Sm</td><td>338</td><td>420</td><td>-19.5%</td><td>500</td><td>558</td><td>-10.4%</td><td>643</td><td>657</td><td>-2.2%</td></tr><tr><td>NPAT to owners of parent</td><td>Sm</t",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "2026dbaa77d1302b",
        "value": -0.022000000000000002,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "8</td><td>420</td><td>-19.5%</td><td>500</td><td>558</td><td>-10.4%</td><td>643</td><td>657</td><td>-2.2%</td></tr><tr><td>NPAT to owners of parent</td><td>Sm</td><td>308</td><td>390</td><td>-21.0%</t",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "d9a68e8af46e3288",
        "value": -0.21,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "</td><td>-2.2%</td></tr><tr><td>NPAT to owners of parent</td><td>Sm</td><td>308</td><td>390</td><td>-21.0%</td><td>460</td><td>518</td><td>-11.3%</td><td>592</td><td>610</td><td>-3.1%</td></tr><tr><td",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "5f63a82da784176e",
        "value": -0.113,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "owners of parent</td><td>Sm</td><td>308</td><td>390</td><td>-21.0%</td><td>460</td><td>518</td><td>-11.3%</td><td>592</td><td>610</td><td>-3.1%</td></tr><tr><td>Per share metrics</td><td></td><td></td",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "25b6636e91fc7fe1",
        "value": -0.031,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "8</td><td>390</td><td>-21.0%</td><td>460</td><td>518</td><td>-11.3%</td><td>592</td><td>610</td><td>-3.1%</td></tr><tr><td>Per share metrics</td><td></td><td></td><td></td><td></td><td></td><td></td><",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "449e74ac70bc3b84",
        "value": -0.221,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "<td></td></tr><tr><td>EPS (post CARES, diluted)</td><td>&#36;/shr</td><td>1.28</td><td>1.65</td><td>-22.1%</td><td>1.94</td><td>2.21</td><td>-12.0%</td><td>2.52</td><td>2.61</td><td>-3.6%</td></tr><tr",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "62bffff21f48fab5",
        "value": -0.12,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "luted)</td><td>&#36;/shr</td><td>1.28</td><td>1.65</td><td>-22.1%</td><td>1.94</td><td>2.21</td><td>-12.0%</td><td>2.52</td><td>2.61</td><td>-3.6%</td></tr><tr><td>DPS</td><td>&#36;/shr</td><td>0.94</",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "53c5cbb938750463",
        "value": -0.036000000000000004,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "><td>1.65</td><td>-22.1%</td><td>1.94</td><td>2.21</td><td>-12.0%</td><td>2.52</td><td>2.61</td><td>-3.6%</td></tr><tr><td>DPS</td><td>&#36;/shr</td><td>0.94</td><td>0.94</td><td>-0.5%</td><td>1.05</t",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "f08edecb67d2222d",
        "value": -0.005,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "/td><td>2.61</td><td>-3.6%</td></tr><tr><td>DPS</td><td>&#36;/shr</td><td>0.94</td><td>0.94</td><td>-0.5%</td><td>1.05</td><td>1.24</td><td>-15.3%</td><td>1.45</td><td>1.56</td><td>-6.8%</td></tr><tr>",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "0196ca4026f3e9d1",
        "value": -0.153,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "<td>DPS</td><td>&#36;/shr</td><td>0.94</td><td>0.94</td><td>-0.5%</td><td>1.05</td><td>1.24</td><td>-15.3%</td><td>1.45</td><td>1.56</td><td>-6.8%</td></tr><tr><td>Analysis</td><td></td><td></td><td><",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "7d509f9e5c98f86f",
        "value": -0.068,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "d><td>0.94</td><td>-0.5%</td><td>1.05</td><td>1.24</td><td>-15.3%</td><td>1.45</td><td>1.56</td><td>-6.8%</td></tr><tr><td>Analysis</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "ec8e2418b87bb0a6",
        "value": 0.124,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>EBITDA margin</td><td>%</td><td>12.4%</td><td>12.9%</td><td>-0.5</td><td>13.2%</td><td>13.5%</td><td>-0.3</td><td>13.9%</td><td>13.9",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "2f557e6a64683256",
        "value": 0.129,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "</td><td></td><td></td><td></td><td></td></tr><tr><td>EBITDA margin</td><td>%</td><td>12.4%</td><td>12.9%</td><td>-0.5</td><td>13.2%</td><td>13.5%</td><td>-0.3</td><td>13.9%</td><td>13.9%</td><td>0.0<",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "f48a75a362a0254e",
        "value": 0.132,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "</td><td></td></tr><tr><td>EBITDA margin</td><td>%</td><td>12.4%</td><td>12.9%</td><td>-0.5</td><td>13.2%</td><td>13.5%</td><td>-0.3</td><td>13.9%</td><td>13.9%</td><td>0.0</td></tr><tr><td>EBIT margi",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "2e07454713db7603",
        "value": 0.135,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "</tr><tr><td>EBITDA margin</td><td>%</td><td>12.4%</td><td>12.9%</td><td>-0.5</td><td>13.2%</td><td>13.5%</td><td>-0.3</td><td>13.9%</td><td>13.9%</td><td>0.0</td></tr><tr><td>EBIT margin</td><td>%</t",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "22740d7bb11c09dc",
        "value": 0.139,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "/td><td>%</td><td>12.4%</td><td>12.9%</td><td>-0.5</td><td>13.2%</td><td>13.5%</td><td>-0.3</td><td>13.9%</td><td>13.9%</td><td>0.0</td></tr><tr><td>EBIT margin</td><td>%</td><td>5.8%</td><td>6.6%</td",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "68b5df53dbfd2e99",
        "value": 0.139,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "<td>12.4%</td><td>12.9%</td><td>-0.5</td><td>13.2%</td><td>13.5%</td><td>-0.3</td><td>13.9%</td><td>13.9%</td><td>0.0</td></tr><tr><td>EBIT margin</td><td>%</td><td>5.8%</td><td>6.6%</td><td>-0.8</td>",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "31ac8ceb99783148",
        "value": 0.057999999999999996,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "/td><td>-0.3</td><td>13.9%</td><td>13.9%</td><td>0.0</td></tr><tr><td>EBIT margin</td><td>%</td><td>5.8%</td><td>6.6%</td><td>-0.8</td><td>6.6%</td><td>7.0%</td><td>-0.4</td><td>7.4%</td><td>7.5%</td>",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "30a8108782af9909",
        "value": 0.066,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "/td><td>13.9%</td><td>13.9%</td><td>0.0</td></tr><tr><td>EBIT margin</td><td>%</td><td>5.8%</td><td>6.6%</td><td>-0.8</td><td>6.6%</td><td>7.0%</td><td>-0.4</td><td>7.4%</td><td>7.5%</td><td>-0.1</td>",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "eaf32fbdc9dbd891",
        "value": 0.066,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "%</td><td>0.0</td></tr><tr><td>EBIT margin</td><td>%</td><td>5.8%</td><td>6.6%</td><td>-0.8</td><td>6.6%</td><td>7.0%</td><td>-0.4</td><td>7.4%</td><td>7.5%</td><td>-0.1</td></tr><tr><td>Net margin</t",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "6fee258dfd39d4dd",
        "value": 0.07,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "</td></tr><tr><td>EBIT margin</td><td>%</td><td>5.8%</td><td>6.6%</td><td>-0.8</td><td>6.6%</td><td>7.0%</td><td>-0.4</td><td>7.4%</td><td>7.5%</td><td>-0.1</td></tr><tr><td>Net margin</td><td>%</td><",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "924ae4a61e8ff454",
        "value": 0.07400000000000001,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "gin</td><td>%</td><td>5.8%</td><td>6.6%</td><td>-0.8</td><td>6.6%</td><td>7.0%</td><td>-0.4</td><td>7.4%</td><td>7.5%</td><td>-0.1</td></tr><tr><td>Net margin</td><td>%</td><td>1.6%</td><td>2.1%</td><",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "5f5db184aead35d2",
        "value": 0.075,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "</td><td>5.8%</td><td>6.6%</td><td>-0.8</td><td>6.6%</td><td>7.0%</td><td>-0.4</td><td>7.4%</td><td>7.5%</td><td>-0.1</td></tr><tr><td>Net margin</td><td>%</td><td>1.6%</td><td>2.1%</td><td>-0.5</td><",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "afd4fd67ebc326df",
        "value": 0.016,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "%</td><td>-0.4</td><td>7.4%</td><td>7.5%</td><td>-0.1</td></tr><tr><td>Net margin</td><td>%</td><td>1.6%</td><td>2.1%</td><td>-0.5</td><td>2.3%</td><td>2.7%</td><td>-0.4</td><td>2.9%</td><td>3.1%</td>",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "8b9dca68536b6a8d",
        "value": 0.021,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "4</td><td>7.4%</td><td>7.5%</td><td>-0.1</td></tr><tr><td>Net margin</td><td>%</td><td>1.6%</td><td>2.1%</td><td>-0.5</td><td>2.3%</td><td>2.7%</td><td>-0.4</td><td>2.9%</td><td>3.1%</td><td>-0.2</td>",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "f3daf197deff5c69",
        "value": 0.023,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "%</td><td>-0.1</td></tr><tr><td>Net margin</td><td>%</td><td>1.6%</td><td>2.1%</td><td>-0.5</td><td>2.3%</td><td>2.7%</td><td>-0.4</td><td>2.9%</td><td>3.1%</td><td>-0.2</td></tr></table> Source: BofA",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "f847221b41313088",
        "value": 0.027000000000000003,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "1</td></tr><tr><td>Net margin</td><td>%</td><td>1.6%</td><td>2.1%</td><td>-0.5</td><td>2.3%</td><td>2.7%</td><td>-0.4</td><td>2.9%</td><td>3.1%</td><td>-0.2</td></tr></table> Source: BofA Global Resea",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "17d840cc6c8c106f",
        "value": 0.028999999999999998,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "gin</td><td>%</td><td>1.6%</td><td>2.1%</td><td>-0.5</td><td>2.3%</td><td>2.7%</td><td>-0.4</td><td>2.9%</td><td>3.1%</td><td>-0.2</td></tr></table> Source: BofA Global Research estimates BofA GLOBAL ",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "c399c8bb73f98e09",
        "value": 0.031,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "</td><td>1.6%</td><td>2.1%</td><td>-0.5</td><td>2.3%</td><td>2.7%</td><td>-0.4</td><td>2.9%</td><td>3.1%</td><td>-0.2</td></tr></table> Source: BofA Global Research estimates BofA GLOBAL RESEARCH We m",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "852906ab09400662",
        "value": 0.14,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "GLOBAL RESEARCH We make the following changes for FY26: · AUS: (1) lower FY26 EBITDA margin from 14% to 13.2% reflecting lower margin Joondalup contract following state price funding. We forecast AUS",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "2df2639aeb39d462",
        "value": 0.132,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "RESEARCH We make the following changes for FY26: · AUS: (1) lower FY26 EBITDA margin from 14% to 13.2% reflecting lower margin Joondalup contract following state price funding. We forecast AUS EBIT to",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "33a1bacf5e651688",
        "value": 0.02,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "ting lower margin Joondalup contract following state price funding. We forecast AUS EBIT to grow by 2% in FY26 · UK: (1) increase hospital revenue growth to 10% (from 7%) reflecting higher NHS volumes",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "c4f9ad2a5b76f24e",
        "value": 0.1,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "funding. We forecast AUS EBIT to grow by 2% in FY26 · UK: (1) increase hospital revenue growth to 10% (from 7%) reflecting higher NHS volumes · Elysium: (1) Lower EBITDA margin to 6% (from 11%) reflec",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "8189634aae57fc7e",
        "value": 0.07,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "We forecast AUS EBIT to grow by 2% in FY26 · UK: (1) increase hospital revenue growth to 10% (from 7%) reflecting higher NHS volumes · Elysium: (1) Lower EBITDA margin to 6% (from 11%) reflect more ch",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "6b0d3f4e3dfb7db1",
        "value": 0.06,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "evenue growth to 10% (from 7%) reflecting higher NHS volumes · Elysium: (1) Lower EBITDA margin to 6% (from 11%) reflect more challenging trading conditions. We forecast Elysium to generate an EBIT lo",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "e5e8c8f712799707",
        "value": 0.11,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "owth to 10% (from 7%) reflecting higher NHS volumes · Elysium: (1) Lower EBITDA margin to 6% (from 11%) reflect more challenging trading conditions. We forecast Elysium to generate an EBIT loss of &#3",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "64cda3d9b4ecf362",
        "value": 0.05,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "s of &#36;17m in FY26 (compared to &#36;42m loss in FY25) · France: (1) Increase revenue growth to 5% (from 3%) but lower EBITDA margin from 13.2% to 12.3% in line with FY25 margins · Nordics: no chan",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "1e5fe7146d4f7a1a",
        "value": 0.03,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": ";17m in FY26 (compared to &#36;42m loss in FY25) · France: (1) Increase revenue growth to 5% (from 3%) but lower EBITDA margin from 13.2% to 12.3% in line with FY25 margins · Nordics: no changes · In",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "15a18a1c50eb8ef6",
        "value": 0.132,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "m loss in FY25) · France: (1) Increase revenue growth to 5% (from 3%) but lower EBITDA margin from 13.2% to 12.3% in line with FY25 margins · Nordics: no changes · Increase interest expense to &#36;60",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "819ae097d066da55",
        "value": 0.12300000000000001,
        "unit": "percentage",
        "metric_type": "percentage",
        "context": "FY25) · France: (1) Increase revenue growth to 5% (from 3%) but lower EBITDA margin from 13.2% to 12.3% in line with FY25 margins · Nordics: no changes · Increase interest expense to &#36;606m given R",
        "provenance": {
          "page": 4
        }
      },
      {
        "num_id": "46d6cdd2acff6212",
        "value": 39.0,
        "unit": "$",
        "metric_type": "currency",
        "context": "ce objective basis & risk ## Ramsay Health Care Limited (RMSYF) Our price objective for RHC of A\\\\$39/share is based on a blended discounted cash flow and multiple based valuation methodology. DCF val",
        "provenance": {
          "page": 5
        }
      }
    ],
    "claims": [],
    "relations": [],
    "extraction_summary": {
      "figures_count": 1,
      "tables_count": 0,
      "numerical_data_count": 149,
      "passages_count": 64,
      "entities_count": 20
    }
  }
}